Submit Deal

Submit Deal

Cover Image Andrew Goodman

Andrew Goodman

Partner at Paul Hastings

Lawyer

Deal Bio

Total Deals22

Valued Deals19

Total Value£ 36.99 B

Avg. Deal Size£ 1.95 B

Market Context

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Andrew Goodman

Sort

25 Feb 2019|Canada|Pharmaceuticals

Target: CLEMENTIA PHARMACEUTICALS

Bidder: IPSEN

9 Service Providers

4 Target | 5 Bidder

41 Dealmakers

14 Target | 27 Bidder

£ 995 M

Value

29 Apr 2020|United States|Biotechnology

Target: ADICET BIO INC

Bidder: RESTORBIO INC

17 Service Providers

2 Target | 6 Bidder | 9 Vendor

45 Dealmakers

8 Target | 27 Bidder | 10 Vendor

n/a

Value

06 Jul 2020|United States|Biotechnology

Target: KIQ LLC

Bidder: UNUM THERAPEUTICS INC

7 Service Providers

2 Target | 5 Bidder

13 Dealmakers

1 Target | 12 Bidder

n/a

Value

10 Sep 2020|United States|IT Services: Other

Target: VIRTUSA CORPORATION

Bidder: BPEA EQT

17 Service Providers

8 Target | 8 Bidder | 1 Vendor

57 Dealmakers

16 Target | 39 Bidder | 2 Vendor

£ 1.54 B

Value

01 Dec 2020|United States|Software

Target: SLACK TECHNOLOGIES

Bidder: SALESFORCE INC

16 Service Providers

7 Target | 9 Bidder

86 Dealmakers

57 Target | 29 Bidder

£ 20.71 B

Value

10 Dec 2020|United States|Pharmaceuticals

Target: NEOS THERAPEUTICS

Bidder: AYTU BIOSCIENCE

9 Service Providers

5 Target | 4 Bidder

9 Dealmakers

5 Target | 4 Bidder

£ 34 M

Value

05 Apr 2021|United States|Media Agencies

Target: LEAF GROUP LTD

Bidder: GRAHAM HOLDINGS COMPANY

8 Service Providers

6 Target | 2 Bidder

20 Dealmakers

16 Target | 4 Bidder

£ 233 M

Value

17 May 2021|United States|Pharmaceuticals

Target: AADI BIOSCIENCE INC

Bidder: AERPIO PHARMACEUTICALS INC

22 Service Providers

4 Target | 18 Bidder

44 Dealmakers

23 Target | 21 Bidder

n/a

Value

24 May 2021|United States|Pharmaceuticals

Target: STRONGBRIDGE

Bidder: XERIS PHARMACEUTICALS

11 Service Providers

7 Target | 4 Bidder

53 Dealmakers

19 Target | 34 Bidder

£ 188 M

Value

19 Apr 2022|United States|Biotechnology

Target: CHECKMATE PHARMACEUTICALS

Bidder: REGENERON

7 Service Providers

5 Target | 2 Bidder

62 Dealmakers

48 Target | 14 Bidder

£ 191 M

Value

01 Sep 2022|United States|Biotechnology

Target: FORMA THERAPEUTICS

Bidder: NOVO NORDISK

9 Service Providers

6 Target | 3 Bidder

65 Dealmakers

46 Target | 19 Bidder

£ 944 M

Value

19 Jan 2023|United States|Biotechnology

Target: CONCERT PHARMACEUTICALS

Bidder: SUN PHARMACEUTICAL INDUSTRIES LTD

10 Service Providers

5 Target | 5 Bidder

55 Dealmakers

40 Target | 15 Bidder

£ 346 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy